BSECompany Update5d ago · 14 Aug 2026, 06:59 pm

Weblink of Audio Transcript for the earnings call held on 14th August, 2026 for Q1FY2026-27

Natco Pharma Ltd · 524816

✦ AI SummaryResults

Natco Pharma Ltd has announced the weblink of the audio transcript for its Q1FY2026-27 earnings call held on August 14, 2026.

Analysis Scores

Earnings Impact5/10

Growth Catalyst2/10

Governance Concern1/10

Regulatory Risk1/10

Balance Sheet Risk1/10

Liquidity Impact5/10

Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

Full Announcement

Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Attachments (1)

📄

d1329794-ed70-48b4-8fef-9e96318c1f3d.pdf

pdf

Download →

View document text

14th August, 2026 Corporate Relationship Department Manager – Listing M/s. BSE Ltd. M/s. National Stock Exchange of India Ltd Mumbai 400 001 Mumbai 400 051 Scrip Code: 524816 Scrip Code: NATCOPHARM Dear Sir Sub:- Audio weblink of earnings conference call held on August 14, 2026 Ref:- Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 We are providing herewith the Audio weblink of the Company's earnings conference call for Q1 FY26-27 held on August 14, 2026. The same available on the website of the Company athttps://admin.natcopharma.co.in/wp-content/uploads/2026/08/Q1FY27.mp3 Thanking you Yours faithfully For NATCO Pharma Limited Ch. Venkat Ramesh Company Secretary & Compliance Officer